Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

被引:0
|
作者
Vincent Walter
Chiara Fischer
Thomas M. Deutsch
Catherine Ersing
Juliane Nees
Florian Schütz
Carlo Fremd
Eva-Maria Grischke
Peter Sinn
Sara Y. Brucker
Andreas Schneeweiss
Andreas D. Hartkopf
Markus Wallwiener
机构
[1] University Hospital Tuebingen,Department of Obstetrics and Gynecology
[2] University Hospital Heidelberg,Department of Obstetrics and Gynecology
[3] National Center for Tumor Diseases (NCT),Division of Gynecologic Oncology
[4] German Cancer Research Center,Department of Pathology
[5] University Hospital Heidelberg,undefined
来源
Breast Cancer Research and Treatment | 2020年 / 183卷
关键词
Metastatic breast cancer; Receptor status discordance; Distant metastasis; Estrogen receptor (ER); Progesterone receptor (PR); Human epidermal growth factor receptor 2 (HER2);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:137 / 144
页数:7
相关论文
共 50 条
  • [41] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Yiting Geng
    Xiaofeng Chen
    Jinrong Qiu
    Yue Zhou
    Jian Wang
    Lingxiang Liu
    Yongfeng Shao
    Yongmei Yin
    International Journal of Clinical Oncology, 2014, 19 : 303 - 311
  • [42] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Geng, Yiting
    Chen, Xiaofeng
    Qiu, Jinrong
    Zhou, Yue
    Wang, Jian
    Liu, Lingxiang
    Shao, Yongfeng
    Yin, Yongmei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) : 303 - 311
  • [43] An advanced refractory breast cancer patient with human epidermal growth factor receptor 2 discordance: a case report
    Hua, Yijia
    Sun, Chunxiao
    Yang, Fan
    Yang, Yiqi
    Bao, Shengnan
    Yan, Xueqi
    Zeng, Tianyu
    Li, Wei
    Yin, Yongmei
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [44] Comparisons between core needle biopsy and definite surgery in estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expressions in breast carcinoma
    Hsiao, Y.
    Chen, J.
    Kuo, S.
    Chen, D.
    Chou, M.
    Chen, S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 229 - 229
  • [45] Characterization of Estrogen Receptor Low Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
    Li, Ming
    Lv, Hong
    Shui, Ruohong
    Lu, Hongfen
    Yang, Wentao
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 151 - 151
  • [46] Characterization of Estrogen Receptor Low Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
    Li, Ming
    Lv, Hong
    Shui, Ruohong
    Lu, Hongfen
    Yang, Wentao
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 151 - 151
  • [47] EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN-BREAST CANCERS - CORRELATION WITH ESTROGEN AND PROGESTERONE RECEPTORS
    DELARUE, JC
    FRIEDMAN, S
    MOURIESSE, H
    MAYLEVIN, F
    SANCHOGARNIER, H
    CONTESSO, G
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 11 (02) : 173 - 178
  • [48] Methylated p16 gene is associated with negative expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer
    Zhang, Shun-Li
    Wang, Ya-Qi
    Zhang, Jing-Hua
    Hu, Ji-Wei
    Ma, Jie
    Gu, Zheng
    Wang, Yu
    Chen, Jing-Jing
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (03) : 530 - 536
  • [49] Discordance in Estrogen Receptor, Progesterone Receptor and HER2 Status between Breast Primary Cancers and Respective Recurrences
    Budwit, D. A.
    O'Connor, S. M.
    Anders, C. K.
    MODERN PATHOLOGY, 2013, 26 : 32A - 32A
  • [50] Discordance in Estrogen Receptor, Progesterone Receptor and HER2 Status between Breast Primary Cancers and Respective Recurrences
    Budwit, D. A.
    O'Connor, S. M.
    Anders, C. K.
    LABORATORY INVESTIGATION, 2013, 93 : 32A - 32A